ARF6 as a novel activator of HIF-2alpha in pulmonary arterial hypertension
A. L. Fellows, C.-N. Chen, C. Xie, N. Iyer, L. Schmidt, X. Yin, M. Mayr, A. S. Cowburn, L. Zhao, B. Wojciak-Stothard
This study identifies ARF6 as a novel activator of HIF-2alpha in pulmonary arterial hypertension and shows that the antibiotic CTC inhibits this pathway.
bioRxiv · Sep 15, 2023Cell Biology